Team/Members of the group:

• Prof Karen Cadoo, Consultant Medical Oncologist and Cancer Geneticist, St James Hospital, Dublin, Ireland
• A/Prof. Emer Guinan, Associate Professor in Cancer Rehabilitation and Survivorship, Trinity College Dublin, Ireland
• Prof Alanna Rahm, Genetic counsellor and Program Director, National Institutes of Health, USA
• Jennifer Nuk, Genetic Counsellor and Practice lead – Hereditary Cancer Program, British Columbia, Canada
• Dr Terri McVeigh, Consultant Geneticist, Cancer Genetic Service, Royal Marsden Hospital, London, UK, Roberta
• Horgan and Pat Fahey, Lynch syndrome Ireland patient support group and
• Alekhya Narravula, Genetic Counsellor, CEO and founder of GeneLinx.

Close Collaborators:
Prof Alanna Rahm, Genetic counsellor and Program Director, National Institutes of Health USA

Main Funders: 
Irish Cancer Society

Active research programmes: 
Rosie is a research affiliate with the University of Sydney in Australia and part of the clinical leadership academic team collaborating on genomic translation research partnerships. For further information click here, https://sydneyhealthpartners.org.au/genomics/. Her leadership, expertise in genetic counselling and translational health service research has brought together a global partnership to the recently funded Irish Cancer Society allied health research award. The findings of the research will inform the implementation of the NCCP Hereditary Cancer Model of Care. The award brings timely focus to Genetic Counsellors, an allied health profession with limited visibility and recognition in Irish healthcare, and is an exemplar being the first to be awarded to a genetic counsellor.

Additional Information:
Rosie has considerable experience working on innovative health solutions and clinical research focusing on the integration of genomic testing into the routine care of cancer patients. Rosie is a member of the New South Wales (NSW) translation and service delivery committee, part of the NSW Ministry of Health in Australia providing strategic direction in guiding the health system to integrate genomic testing into routine care. She is a member of; the National Society of Genetic Counsellors Global Genetic Counsellors PhD mentoring group in the USA and the European Board of Genetic counsellors. In Ireland, Rosie is a member of the Hereditary Cancer Steering Group as part of the National Cancer Control Programme providing expertise in the development and structure of cancer genomic services, for Irish healthcare. She is a member of the Public and Patient Involvement committee as part of the implementation phase of the Irish genomics strategy.